The effect of SCN1A mutations on patient-derived GABAergic neurons: What are the implications for future Dravet syndrome therapeutics?

Norimichi Higurashi, Hideyuki Okano, Shinichi Hirose

Research output: Contribution to journalEditorialpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)487-489
Number of pages3
JournalFuture Neurology
Issue number5
Publication statusPublished - 2013 Sept


  • Dravet syndrome
  • GABA
  • SCN1A
  • epilepsy
  • induced pluripotent stem cells
  • treatment

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this